2-nitro-N-(2-trifluoromethylphenyl)benzamide | 314053-91-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-nitro-N-(2-trifluoromethylphenyl)benzamide
• 英文别名: N-(2-trifluoromethylphenyl)-2-nitrobenzamide；2-nitro-N-[2-(trifluoromethyl)phenyl]benzamide
• CAS: 314053-91-3
• 化学式: C₁₄H₉F₃N₂O₃
• mdl: MFCD00783895
• 分子量: 310.232
• InChiKey: MORUOUXZJAHZBA-UHFFFAOYSA-N

物化性质

• 熔点：
  179-180 °C(Solv: chloroform (67-66-3))
• 沸点：
  339.6±42.0 °C(Predicted)
• 密度：
  1.452±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  74.9
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-nitro-N-(2-trifluoromethylphenyl)benzamide 在 palladium on activated charcoal 氢气 作用下， 以 乙酸乙酯 为溶剂， 以99%的产率得到N-(2-trifluoromethylphenyl)-2-aminobenzamide
  参考文献：
  名称：

  Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor

  摘要：

  Although cyclooxygenase-1 (COX-1) inhibition is thought to be a major mechanism of gastric damage by nonsteroidal anti-inflammatory drugs (NSAIDs), some COX-1-selective inhibitors exhibit strong analgesic effects without causing gastric damage. However, it is not clear whether their analgesic effects are attributable to COX-1-inhibitory activity or other bioactivities. Here, we report that N-(5-amino-2-pyridinyl)-4(trifluoromethyl)benzamide (18f, TFAP), which has a structure clearly different from those of currently available COX-1-selective inhibitors, is a potent COX-1-selective inhibitor (COX-1IC(50) = 0.80 +/- 0.05 mu M, COX-2IC(50) = 210 I mu M). This compound causes little gastric damage in rats even at an oral dose of 300 mg/kg, though it has an analgesic effect at as low a dose as 10 mg/kg. Our results show that COX-1-selective inhibitors can be analgesic agents without causing gastric damage.

  DOI：

  10.1021/jm701191z
• 作为产物：
  描述：

  邻硝基苯甲酸 在 氯化亚砜 作用下， 以 二氯甲烷 、 氯仿 为溶剂， 反应 3.0h， 生成 2-nitro-N-(2-trifluoromethylphenyl)benzamide
  参考文献：
  名称：

  Copper-Catalyzed Radical Methylation/C–H Amination/Oxidation Cascade for the Synthesis of Quinazolinones

  摘要：

  A copper-catalyzed radical methylation/sp(3) C-H amination/oxidation reaction for the facile synthesis of quinazolinone was developed. In this cascade reaction, dicumyl peroxide acts not only as a useful oxidant but also as an efficient methyl source. Notably, a methyl radical, generated. from peroxide, was confirmed by electron paramagnetic resonance for the first time.

  DOI：

  10.1021/acs.joc.5b00191

文献信息

• Compounds for modulating TRPV3 function
  申请人：Chong A. Jayhong

  公开号：US20070179164A1

  公开（公告）日：2007-08-02

  The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

  本申请涉及化合物和治疗与TRPV3相关的疼痛和其他病症的方法。
• Stannous Chloride in Alcohol:  A One-Pot Conversion of 2-Nitro-<i>N</i>-arylbenzamides to 2,3-Dihydro-1<i>H</i>-quinazoline-4-ones
  作者：Choong Leol Yoo、James C. Fettinger、Mark J. Kurth

  DOI：10.1021/jo050450f

  日期：2005.8.1

  A novel one-step synthesis of 2,3-dihydro-1H-quinazolin-4-ones from 2-nitrobenzamides is reported. These reactions are mediated by stannous chloride in 0.02 M methanolic or ethanolic HCl solution and proceed in good yields.

  报道了由2-硝基苯甲酰胺合成2，3-二氢-1 H-喹唑啉-4-酮的一种新颖的一步法。这些反应由氯化亚锡在0.02 M的甲醇或乙醇的HCl溶液中介导，并以良好的收率进行。
• Compounds for Modulating TRPV3 Function
  申请人：Chong Jayhong A.

  公开号：US20110144135A1

  公开（公告）日：2011-06-16

  The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

  本申请涉及化合物和用于治疗与TRPV3相关的疼痛和其他病症的方法。
• COMPOUNDS FOR MODULATING TRPV3 FUNCTION
  申请人：HYDRA BIOSCIENCES, INC.

  公开号：US20140155417A1

  公开（公告）日：2014-06-05

  The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

  本申请涉及化合物和治疗与TRPV3相关的疼痛和其他疾病的方法。
• Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor
  作者：Hiroki Kakuta、Xiaoxia Zheng、Hiroyuki Oda、Shun Harada、Yukio Sugimoto、Kenji Sasaki、Akihiro Tai

  DOI：10.1021/jm701191z

  日期：2008.4.1

  Although cyclooxygenase-1 (COX-1) inhibition is thought to be a major mechanism of gastric damage by nonsteroidal anti-inflammatory drugs (NSAIDs), some COX-1-selective inhibitors exhibit strong analgesic effects without causing gastric damage. However, it is not clear whether their analgesic effects are attributable to COX-1-inhibitory activity or other bioactivities. Here, we report that N-(5-amino-2-pyridinyl)-4(trifluoromethyl)benzamide (18f, TFAP), which has a structure clearly different from those of currently available COX-1-selective inhibitors, is a potent COX-1-selective inhibitor (COX-1IC(50) = 0.80 +/- 0.05 mu M, COX-2IC(50) = 210 I mu M). This compound causes little gastric damage in rats even at an oral dose of 300 mg/kg, though it has an analgesic effect at as low a dose as 10 mg/kg. Our results show that COX-1-selective inhibitors can be analgesic agents without causing gastric damage.